Share This

Public company info - ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -�H�Shares , 01541.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -�H�Shares, 01541.HK - Cash Flow 2022-12 2021-12
Net Cash Flow from Operating Activities -238,710 -190,541
Net Cash Flow from Return on Investments & Servicing of Finance 7,793 686
　Interest Received 8,580 1,577
　Interest Paid -787 -891
　Dividend Received 0 0
　Dividend Paid 0 0
　Others 0 0
Taxes (Paid) / Refunded 0 0
Net Cash Flow from Investing Activities -8,531 -110,299
　Additions to Fixed Assets -23,224 -108,835
　Disposal of Fixed Assets 0 575
　Increase in Investments 0 -329,000
　Decrease in Investments 0 352,652
　Net Cash Flow with Related Parties 0 0
　Others 14,693 -25,691
Net Cash Flow before Financing Activities -239,448 -300,154
Net Cash Flow from Financing Activities 180,167 793,924
　New Loans 0 10
　Loans Repayment -5,803 -4,782
　Fixed Income/Debt Instruments 0 0
　Repayment of Fixed Income/Debt Instruments 0 0
　Equity Financing 185,970 798,696
　Net Cash Flow with Related Parties 0 0
　Others 0 0
Increase(Decrease) in Cash & Cash Equivalents -59,281 493,770
Cash & Cash Equivalents at Beginning of Year 668,326 183,674
Net Cash Flow due to Change in Exchange Rate/Others 26,167 -9,118
Cash & Cash Equivalents at End of Year 635,212 668,326
Currency Renminbi Renminbi
Unit
Auditor's Opinion 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.